Pediatric Academic Societies'
Annual Meeting

 Sponsored by the:

 Program   |   Exhibits   |   Registration   |   Housing   |   Travel  |   International Attendees   |   Presenters   |   Abstracts   |   CME   |   Press/Media  

 

 

Contact Information

Mail Address:

3400 Research Forest Dr., Ste B-7
The Woodlands, TX  77381 USA

Email:  info@pas-meeting.org

Telephone:  281-419-0052

Facsimile:  281-419-0082

   

2005 PAS Annual Meeting

May 14 –17 
Washington, DC

Washington Convention Center
Renaissance Washington Hotel

 

  

2005 Late-Breaker Abstract Sessions

Saturday, May 14
3:15pm–5:15pm
4855  Late Breakers I:
         Late Breaking Research in Pediatrics

PAS Platform Session ~ WCC, Room 204 AB

Moderator: Paul Young


Monday, May 16
3:00pm–5:00pm
6750  Late Breakers II:
         Clinical Research in Neonatology

PAS Platform Session ~ WCC, Room
147

Moderators: Neil Finer and Richard Martin


3:15*

A Simple Method To Identify GNAS1 Gene Mutation from Peripheral Lymphocytes. A Tip for Genetic Diagnosis of GNAS1 Related Multiple Endocrinopathies Among Masked Somatic Mosaicism. Katsuaki Motomura.     (Late-Breaker Abstract 1)  

3:00

Efficacy and Safety of Methylxanthines in Very-Low-Birth Weight (VLBW) Infants: Preliminary Results from the International Caffeine for Apnea of Prematurity (CAP) Trial. Barbara Schmidt, Robin Roberts, Peter Davis, Lex Doyle, Keith Barrington, Arne Ohlsson, Alfonso Solimano, Win Tin, The CAP Investigators.
(Late-Breaker Abstract 9) 

3:30*

Procalcitonin as a Predictor of Vesicoureteral Reflux After a 1st Urinary Tract Infection in Children: European Validation Study. S. Leroy, C. Romanello, A. Galetto-Lacour, V. Smolkin, B. Korczowski, C. Rodrigo, D. Tuerlinckx, V. Gajdos, M. Contardo, A. Gervaix, R. Halevy, B. Duhl, C. Prat, T. Vander Borght, L. Foix L’Hélias, D. Gendrel, G. Bréart, M. Chalumeau.     (Late-Breaker Abstract 2)

3:15

Population-Based Study of Neonatal Outcomes Following Prenatal SSRI Exposure Using the BC Health Linked Data. Tim F. Oberlander, William Warburton, Jaafar Aghajanian, Clyde Hertzman.     (Late-Breaker Abstract 10)

3:45

Live Attenuated Influenza Vaccine (LAIV) Administration in Schoolchildren Coincident with the 2003–2004 Outbreak Provided Herd Immunity Against a Drifted Influenza Variant A/Fujian/411/2002 (H3N2). Manjusha J. Gaglani, Pedro A. Piedra, Gayla Herschler, Charles Fewlass, W.P. Glezen.   (Late-Breaker Abstract 3)  

3:30

Multicenter Randomized Double-Blind Placebo Controlled Trial of Ibuprofen L-Lysine Intravenous Solution (IV Ibuprofen) in Premature Infants for the Early Treatment of Patent Ductus Arteriosus (PDA). J.V. Aranda for the I.V. Ibuprofen–PDA Study Team and for the Pediatric Pharmacology Research Unit Network (NICHD-PPRU). (Late-Breaker Abstract 11)

4:00

Reducing Early Childhood Overweight: Pediatric Practice Results from a Rural Community Intervention. Barbara A. Dennison, Kathleen F. Sellers, Claire T. Sellers, Ida R. Baker, Patrick A. Burdick.    (Late-Breaker Abstract 4)

3:45

Cluster Randomized Trial of Benchmarking To Improve Survival Free of Bronchopulmonary Dysplasia (BPD). M. Walsh, A. Laptook, S. Buchter, W.A. Engle, M. Rasmussen, S.N. Kazzi, Q. Yao, G. Heldt, W. Rhine, R. Higgins for the NICHD Neonatal Research Network.     (Late-Breaker Abstract 12)

4:15

Novel Strategy for Delivering Influenza Vaccine to Household Contacts of Infants Less Than 6 Months Old. Donna H. Jordan, Ruth A. Merryman, Jane D. Siegel.    (Late-Breaker Abstract 5)  

4:00

A Community-Based, Randomized Trial of Newborn Skin Cleansing with Chlorhexidine on Neonatal Mortality in Southern Nepal. James M. Tielsch, Gary Darmstadt, Luke C. Mullany, Subarna K. Khatry, Joanne Katz, Steven C. LeClerq, Shardaram Shrestha, Ramesh Adhikari.     (Late-Breaker Abstract 13)

4:30

Medication Errors in Ambulatory Pediatric Patients. Rainu Kaushal, Donald A. Goldmann, Carol A. Keohane, Melissa Honour, David W. Bates.      (Late-Breaker Abstract 6)

4:15

Does the Introduction of Nasal CPAP Improve Respiratory Outcomes in Premature Infants? Gustavo Pelligra, Mohamed A Abdellatif, Shoo K. Lee.     (Late-Breaker Abstract 14)

4:45

The Effectiveness of a Pentavalent (Human-Bovine) Reassortant Rotavirus Vaccine (PRV) To Reduce Hospitalizations and Emergency Department (ED) Visits for Rotavirus Gastroenteritis. R. Itzler, D. Matson, T.  Vesikari, M. Coia, J. Cook, G. Davies, P. Heaton, J. Heyse, G. Koch for REST Study Team.     (Late-Breaker Abstract 7)

4:30

Randomized Controlled Trial for the Prevention of Intraventricular Hemorrhage by Indomethacin in Japanese Extremely Low Birthweight Infants. Masanori Fujimura, Shinya Hirano, Satoshi Kusuda, Hirofumi Aotani, Noriyuki Nakanishi.     (Late-Breaker Abstract 15)

5:00

Human Coronavirus (HCoV) NL-63 in the Respiratory Tract Is Not Associated with Acute Kawasaki Syndrome (KS). Jane C. Burns, Hiroko Shike, Chisato Shimizu, Sharon L. Reed, John V. Williams, Susan C. Baker, Vivek R. Nerurkar, Saguna Verma, Richard Yanagihara, Marian E Melish, Stanford T. Shulman, Anne H. Rowley.     (Late-Breaker Abstract 8)

4:45

Long-Term Outcomes of the Novel Peptide-Containing Synthetic Surfactant, Lucinactant (Surfaxin[reg]) vs. Animal-Derived and Synthetic, Non–Protein-Containing Synthetic Surfactants in Very Preterm Infants. Fernando Moya, Sunil Sinha, Janusz Gadzinowski, Robert Segal, Jan Mazela, Carlos Guardia, Genzhou Liu.     (Late-Breaker Abstract 16)

 
 

   
PDF files require the use of the free Adobe Acrobat Reader. Click here if you need to download this file to your computer. 

Copyright: All information contained in this Website is the property of the Pediatric Academic Societies unless otherwise noted. Duplication of any information contained herein for reasons other than personal use requires the expressed written permission of PAS. For comments or concerns about the website, please contact webmaster@pas-meeting.org.

Last Updated: September 26, 2006